Strathspey Crown Holdings Group, Llc - Net Worth and Insider Trading

Strathspey Crown Holdings Group, Llc Net Worth

The estimated net worth of Strathspey Crown Holdings Group, Llc is at least $2 Million dollars as of 2024-11-05. Strathspey Crown Holdings Group, Llc is the 10% Owner of AEON Biopharma Inc and owns about 2,031,773 shares of AEON Biopharma Inc (AEON) stock worth over $2 Million. Details can be seen in Strathspey Crown Holdings Group, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Strathspey Crown Holdings Group, Llc has not made any transactions after 2023-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Strathspey Crown Holdings Group, Llc

Strathspey Crown Holdings Group, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Strathspey Crown Holdings Group, Llc owns 1 companies in total, including AEON Biopharma Inc (AEON) .

Click here to see the complete history of Strathspey Crown Holdings Group, Llc’s form 4 insider trades.

Insider Ownership Summary of Strathspey Crown Holdings Group, Llc

Ticker	Comapny	Transaction Date	Type of Owner
AEON	AEON Biopharma Inc	2023-08-11	10 percent owner

Strathspey Crown Holdings Group, Llc Latest Holdings Summary

Strathspey Crown Holdings Group, Llc currently owns a total of 1 stock. Strathspey Crown Holdings Group, Llc owns 2,031,773 shares of AEON Biopharma Inc (AEON) as of August 11, 2023, with a value of $2 Million.

Latest Holdings of Strathspey Crown Holdings Group, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AEON	AEON Biopharma Inc	2023-08-11	2,031,773	0.87	1,767,846

Holding Weightings of Strathspey Crown Holdings Group, Llc

Strathspey Crown Holdings Group, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Strathspey Crown Holdings Group, Llc has made a total of 1 transactions in AEON Biopharma Inc (AEON) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AEON Biopharma Inc is the sale of 7,380,394 shares on August 11, 2023, which brought Strathspey Crown Holdings Group, Llc around $74 Million.

Insider Trading History of Strathspey Crown Holdings Group, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Strathspey Crown Holdings Group, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Strathspey Crown Holdings Group, Llc Ownership Network

Ownership Network List of Strathspey Crown Holdings Group, Llc

No Data

Ownership Network Relation of Strathspey Crown Holdings Group, Llc

Strathspey Crown Holdings Group, Llc Owned Company Details

What does AEON Biopharma Inc do?

Who are the key executives at AEON Biopharma Inc?

Strathspey Crown Holdings Group, Llc is the 10 percent owner of AEON Biopharma Inc. Other key executives at AEON Biopharma Inc include director & 10 percent owner Robert J Palmisano , Chief Financial Officer Peter A Reynolds , and 10 percent owner Vikram Malik .

AEON Biopharma Inc (AEON) Insider Trades Summary

Over the past 18 months, Strathspey Crown Holdings Group, Llc made 1 insider transaction in AEON Biopharma Inc (AEON) with a net sale of 7,380,394.

In summary, during the past 3 months, insiders sold 0 shares of AEON Biopharma Inc (AEON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,380,394 shares of AEON Biopharma Inc (AEON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,380,394 shares.

AEON Biopharma Inc (AEON)'s detailed insider trading history can be found in Insider Trading Tracker table.

AEON Biopharma Inc Insider Transactions

No Available Data

Strathspey Crown Holdings Group, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Strathspey Crown Holdings Group, Llc. You might contact Strathspey Crown Holdings Group, Llc via mailing address: 4040 Macarthur Blvd., Suite 210, Newport Beach Ca 92660.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.